Sangam India Ltd approves up to 18 lakh warrants worth Rs 100 crore and Rs 1,500 crore capex

What Sangam India Ltd announced

On 18 July 2026, the Board of Directors of Sangam India Ltd met at its registered office in Bhilwara and approved three key items:

1. The unaudited standalone and consolidated financial results for the quarter ended 30 June 2026.
2. A preferential issue of up to 18,00,000 (eighteen lakh) warrants convertible into equity shares, priced at Rs 555.56 per warrant, aggregating to Rs 100,00,08,000 (≈ Rs 100 crore), to be allotted to the promoter group.
3. A capital expenditure (CapEx) plan of approximately Rs 1,500 crore for an expansion project. The board’s resolutions are filed under Regulation 30 and 33 of the SEBI (LODR) Regulations, 2015 and are now on record with both NSE and BSE.

"The warrants shall be convertible into equal number of equity shares on conversion within 18 months from the date of allotment." – Board resolution, 18 July 2026.

Details of the preferential warrant issue

The warrant issue is structured as a preferential issue under Chapter V of the SEBI ICDR Regulations, 2018. Key parameters are:

• Number of warrants: 18,00,000 (eighteen lakh).
• Issue price: Rs 555.56 per warrant, which translates to an aggregate issue size of Rs 100,00,08,000 (one hundred crore and eight thousand rupees).
• Face value of underlying equity shares: Rs 10 per share.
• Allottees: Promoter/Promoter’s group as per the attached list; the filing mentions seven (7) proposed investors.
• Conversion window: Warrants may be converted into an equal number of equity shares within 18 months from the date of allotment.
• Post‑subscription shareholding (as per Annexure‑I): After conversion, promoter holdings would rise to 71.54 %, public shareholders would hold 26.67 %, and non‑promoter non‑public investors 1.80 % of the total post‑issue equity. The issue is subject to approval by the shareholders at the forthcoming Annual General Meeting and to clear all regulatory clearances.

Capital expenditure plan

The board also approved a capital expenditure of roughly Rs 1,500 crore for an expansion project. While the filing does not disclose the nature of the project, it references compliance with SEBI Circular No. SEBI/HO/CFD‑POD‑1/p/CIR/2023/120 (as updated on 30 Jan 2026). The CapEx is expected to be funded through internal accruals and, potentially, the proceeds from the warrant issue, though the filing does not explicitly link the two.

Key facts at a glance

Why this matters for investors

The preferential warrant issue is a dilutive instrument because each warrant, once exercised, will increase the total share count. However, the conversion price of Rs 555.56 per warrant implies a premium to the current market price (the filing does not state the market price, so the premium cannot be quantified). The proceeds, capped at about Rs 100 crore, are earmarked to support the Rs 1,500 crore expansion plan, signalling the company’s intent to scale operations.

For existing shareholders, the post‑conversion shareholding pattern indicates that promoter control will marginally increase (from 70.52 % to 71.54 %). Public shareholders’ proportion will fall slightly, reflecting the dilution effect. The board’s approval of the unaudited Q2 results also provides a regulatory update, though the filing does not disclose the actual numbers, leaving investors to await the detailed financial statements.

Regulatory compliance is a prerequisite for the issue to proceed. The board’s resolutions are subject to shareholder approval at the AGM and clearance from the SEBI and stock exchanges. Until those approvals are obtained, the warrants remain a proposal rather than a completed transaction.

Conclusion

Sangam India Ltd’s board has cleared a Rs 100 crore preferential warrant issue to its promoters and a Rs 1,500 crore capital expenditure for expansion. The warrants, convertible within 18 months, will modestly increase promoter ownership while diluting existing shareholders. The proposals now await shareholder and regulator sign‑off before any funds can be raised or the expansion can commence. Investors should monitor the upcoming AGM results and any subsequent regulatory filings for final confirmation.